Correlation Between the Glasgow Prognostic Score and the Serum Cytokine Profile in Taiwanese Patients with Colorectal Cancer.

IF 2.3 4区 医学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Yen-Lin Yu, Chung-Wei Fan, Wen-Ko Tseng, Pei-Hung Chang, Hsuan-Chih Kuo, Yi-Ping Pan, Kun-Yun Yeh
{"title":"Correlation Between the Glasgow Prognostic Score and the Serum Cytokine Profile in Taiwanese Patients with Colorectal Cancer.","authors":"Yen-Lin Yu,&nbsp;Chung-Wei Fan,&nbsp;Wen-Ko Tseng,&nbsp;Pei-Hung Chang,&nbsp;Hsuan-Chih Kuo,&nbsp;Yi-Ping Pan,&nbsp;Kun-Yun Yeh","doi":"10.1177/17246008211022769","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Glasgow Prognostic Score and circulating cytokine levels are related to the prognosis of colorectal cancer and the severity of chronic inflammation. The association between the Glasgow Prognostic Score and circulating cytokines in colorectal cancer remains unclear.</p><p><strong>Methods: </strong>The levels of 10 circulating cytokines (TNF-α, TGF-β, IFN-γ, IL-1β, IL-4, IL-6, IL-10, IL-12, IL-13, and IL-23) were measured in 128 patients with colorectal cancer. The relationship between the Glasgow Prognostic Score, clinicopathologic variables, and cytokine levels was assessed by univariate and multivariate logistic regression analyses. The correlation among cytokines was also examined.</p><p><strong>Results: </strong>Patients with advanced stage colorectal cancer had lower levels of albumin (<i>P</i> = 0.003), higher levels of C-reactive protein (CRP; <i>P</i> < 0.001), carcinoembryonic antigen (CEA; <i>P</i> < 0.001), interferon (IFN)-γ (<i>P</i> < 0.001), and interleukin (IL)-10 (<i>P</i> = 0.006), and shorter survival outcomes (<i>P</i> < 0.001). Patients with a high Glasgow Prognostic Score (1 or 2) had lower 5-year progression-free survival and poor overall survival (log-rank <i>P</i> < 0.001). A high Glasgow Prognostic Score was significantly correlated with abnormal CEA levels (CEA > 5 ng/mL, <i>P</i> = 0.033), and higher levels of tumor necrosis factor (TNF)-α (TNF-α ⩾ 53.9 pg/mL, <i>P</i> = 0.035) and IL-10 (IL-10 ⩾ 75.95 pg/mL, <i>P</i> = 0.008). TNF-α, IFN-γ, IL-1β, IL-4, IL-6, IL-10, IL-13, and IL-23 were significantly correlated with each other (all <i>P</i> < 0.05). Only IL-10 was correlated with abnormal CEA levels (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>The Glasgow Prognostic Score and level of circulating cytokines have an intergroup correlation, and there is a close association among cytokines in colorectal cancer.</p>","PeriodicalId":50334,"journal":{"name":"International Journal of Biological Markers","volume":"36 2","pages":"40-49"},"PeriodicalIF":2.3000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/17246008211022769","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Biological Markers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17246008211022769","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/6/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Background: The Glasgow Prognostic Score and circulating cytokine levels are related to the prognosis of colorectal cancer and the severity of chronic inflammation. The association between the Glasgow Prognostic Score and circulating cytokines in colorectal cancer remains unclear.

Methods: The levels of 10 circulating cytokines (TNF-α, TGF-β, IFN-γ, IL-1β, IL-4, IL-6, IL-10, IL-12, IL-13, and IL-23) were measured in 128 patients with colorectal cancer. The relationship between the Glasgow Prognostic Score, clinicopathologic variables, and cytokine levels was assessed by univariate and multivariate logistic regression analyses. The correlation among cytokines was also examined.

Results: Patients with advanced stage colorectal cancer had lower levels of albumin (P = 0.003), higher levels of C-reactive protein (CRP; P < 0.001), carcinoembryonic antigen (CEA; P < 0.001), interferon (IFN)-γ (P < 0.001), and interleukin (IL)-10 (P = 0.006), and shorter survival outcomes (P < 0.001). Patients with a high Glasgow Prognostic Score (1 or 2) had lower 5-year progression-free survival and poor overall survival (log-rank P < 0.001). A high Glasgow Prognostic Score was significantly correlated with abnormal CEA levels (CEA > 5 ng/mL, P = 0.033), and higher levels of tumor necrosis factor (TNF)-α (TNF-α ⩾ 53.9 pg/mL, P = 0.035) and IL-10 (IL-10 ⩾ 75.95 pg/mL, P = 0.008). TNF-α, IFN-γ, IL-1β, IL-4, IL-6, IL-10, IL-13, and IL-23 were significantly correlated with each other (all P < 0.05). Only IL-10 was correlated with abnormal CEA levels (P < 0.001).

Conclusion: The Glasgow Prognostic Score and level of circulating cytokines have an intergroup correlation, and there is a close association among cytokines in colorectal cancer.

台湾结直肠癌患者格拉斯哥预后评分与血清细胞因子的相关性研究。
背景:格拉斯哥预后评分和循环细胞因子水平与结直肠癌的预后和慢性炎症的严重程度有关。结直肠癌患者的格拉斯哥预后评分与循环细胞因子之间的关系尚不清楚。方法:测定128例结直肠癌患者外周血10种细胞因子(TNF-α、TGF-β、IFN-γ、IL-1β、IL-4、IL-6、IL-10、IL-12、IL-13、IL-23)水平。通过单变量和多变量logistic回归分析评估格拉斯哥预后评分、临床病理变量和细胞因子水平之间的关系。研究了细胞因子之间的相关性。结果:晚期结直肠癌患者白蛋白水平较低(P = 0.003), c反应蛋白(CRP)水平较高;P < 0.001),癌胚抗原(CEA;P < 0.001),干扰素(IFN)-γ (P < 0.001)和白细胞介素(IL)-10 (P = 0.006),以及较短的生存结果(P < 0.001)。高格拉斯哥预后评分(1或2)的患者5年无进展生存期较低,总生存期较差(log-rank P < 0.001)。高格拉斯哥预后评分与异常CEA水平(CEA > 5 ng/mL, P = 0.033)和更高水平的肿瘤坏死因子(TNF)-α (TNF-α大于或等于53.9 pg/mL, P = 0.035)和IL-10 (IL-10大于或等于75.95 pg/mL, P = 0.008)显著相关。TNF-α、IFN-γ、IL-1β、IL-4、IL-6、IL-10、IL-13、IL-23之间的相关性均显著(P < 0.05)。只有IL-10与CEA异常相关(P < 0.001)。结论:格拉斯哥预后评分与循环细胞因子水平存在组间相关性,细胞因子在结直肠癌中存在密切关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Biological Markers
International Journal of Biological Markers 医学-生物工程与应用微生物
CiteScore
4.10
自引率
0.00%
发文量
43
期刊介绍: IJBM is an international, online only, peer-reviewed Journal, which publishes original research and critical reviews primarily focused on cancer biomarkers. IJBM targets advanced topics regarding the application of biomarkers in oncology and is dedicated to solid tumors in adult subjects. The clinical scenarios of interests are screening and early diagnosis of cancer, prognostic assessment, prediction of the response to and monitoring of treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信